Technical Analysis for SRPT - Sarepta Therapeutics, Inc.

Grade Last Price % Change Price Change
C 123.97 0.75% 0.92
SRPT closed up 0.75 percent on Monday, March 18, 2024, on 47 percent of normal volume. It was able to find support at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
5 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Flat Up

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Doji - Bearish? Reversal 0.00%
Oversold Stochastic Weakness 0.00%
50 DMA Support Bullish 0.75%
Oversold Stochastic Weakness 0.75%
50 DMA Support Bullish 0.17%
Stochastic Buy Signal Bullish 0.17%
Outside Day Range Expansion 0.17%
Oversold Stochastic Weakness 0.17%
50 DMA Support Bullish 1.65%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High about 12 hours ago
60 Minute Opening Range Breakout about 12 hours ago
Up 1% about 14 hours ago
10 DMA Support about 14 hours ago
50 DMA Support about 14 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Sarepta Therapeutics, Inc. Description

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. Its lead product candidate is eteplirsen, an antisense PMO-based therapeutic, which is in Phase IIb clinical development for the treatment of individuals with Duchenne muscular dystrophy. The company is also involved in developing treatments that are in Phase I clinical trials for infectious diseases, including AVI-7288 for Marburg virus; and AVI-7100 for H1N1 influenza virus. In addition, it focuses on developing preclinical research product candidates for the treatment of other neuromuscular, infectious, and rare diseases. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Clinical Development Infectious Diseases Rare Diseases Clinical Research Influenza Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Duchenne Therapeutic Gene Modulation Antisense RNA Sarepta Therapeutics

Is SRPT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 159.89
52 Week Low 55.25
Average Volume 1,123,002
200-Day Moving Average 111.03
50-Day Moving Average 123.39
20-Day Moving Average 128.08
10-Day Moving Average 122.46
Average True Range 4.28
RSI (14) 48.72
ADX 23.37
+DI 21.37
-DI 17.39
Chandelier Exit (Long, 3 ATRs) 130.15
Chandelier Exit (Short, 3 ATRs) 132.50
Upper Bollinger Bands 141.57
Lower Bollinger Band 114.58
Percent B (%b) 0.35
BandWidth 21.07
MACD Line -0.43
MACD Signal Line 0.58
MACD Histogram -1.0087
Fundamentals Value
Market Cap 11.6 Billion
Num Shares 93.5 Million
EPS -7.79
Price-to-Earnings (P/E) Ratio -15.91
Price-to-Sales 10.81
Price-to-Book 15.54
PEG Ratio 159.25
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 128.59
Resistance 3 (R3) 128.56 126.98 127.82
Resistance 2 (R2) 126.98 125.81 127.00 127.56
Resistance 1 (R1) 125.48 125.08 126.23 125.51 127.31
Pivot Point 123.90 123.90 124.28 123.92 123.90
Support 1 (S1) 122.40 122.73 123.15 122.43 120.63
Support 2 (S2) 120.82 122.00 120.84 120.38
Support 3 (S3) 119.32 120.82 120.12
Support 4 (S4) 119.35